Short-term adjunct in the management of obesity in a medically monitored comprehensive regimen of wt reduction based on exercise, diet & behaviour modification in obese patients w/ BMI ≥30 kg/m2 & in overwt patients (BMI 25-29.9 kg/m2) w/ comorbidity.
Dosage/Direction for Use
Adult & childn >12 yr 1 cap daily. Recommended starting dose: 30 mg daily. Recommended continuous or intermittent maintenance dose: 15-30 mg daily depending on responsiveness.
Should be taken with food: Take at breakfast. Avoid taking near bedtime. Swallow whole, do not chew/crush.
Pulmonary artery HTN; existing heart valve abnormalities or heart murmurs; moderate to severe arterial HTN; cerebrovascular disease; severe cardiac disease including arrhythmias, advanced arteriosclerosis; hyperthyroidism; agitated states or a history of psychiatric illness including anorexia nervosa & depression; glaucoma; history of drug/alcohol abuse or dependence. Pregnancy & lactation. Childn <12 yr. Elderly.
Mild HTN, diabetes, established coronary artery disease, epilepsy, patients receiving psychotrophic drugs or antihypertensives. Wt loss should be gradual & controlled. May impair ability to drive or operate machinery.